Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Opioids

September 18, 2019 | Daily News

A group of medicine and public health researchers and historians are calling on an Ohio court overseeing the national multidistrict opioid litigation to ensure that any settlement guarantees full and permanent access to records that contain information about and shed light on the abuse potential and distribution patterns of opioids.

September 17, 2019 | Daily News

Mental health and substance use treatment advocates are calling on Congress to reauthorize funding for mental health clinics, remove barriers to medication-assisted treatment and allow mental health counselors to bill Medicare.

September 16, 2019 | Daily News

The Certified Community Behavioral Health Clinic demonstration program lost its funding Friday (Sept. 13) for the second time this year after a short-term extension lapsed, threatening access to medication-assisted treatment and the jobs of those who work at these clinics, according to patient advocates.

September 13, 2019 | Daily News

Plans say prior authorization for medication-assisted treatment (MAT) for individuals with substance use disorders helps the treatment be used safely and effectively, but providers are worried that prior authorization is a barrier to treatment in the middle of an opioid crisis.

September 12, 2019 | Daily News

The Certified Community Behavioral Health Clinic demonstration program will lose its funding on Friday (Sept. 13) if the Senate does not act to pass another extension, and, despite reassurances by senators that funding is a priority, nothing appears to be moving forward ahead of that deadline.

September 10, 2019 | Daily News

FDA denied a petition from Public Citizen that called for a moratorium on new opioid approvals until the agency’s regulation and review of opioids are revamped.

September 09, 2019 | Daily News

The American Medical Association (AMA) said Medicaid is leading the way in combating the opioid crisis and outlined opportunities for the program to further expand treatment for opioid-use disorders, including by removing barriers to medication-assisted treatment (MAT), providing more non-opioid pain management options and expanding access to providers who treat substance-use disorders.

September 05, 2019 | Daily News

Though FDA and stakeholders have taken steps to promote federally recommended methods to dispose of unused opioids, little is known about whether such efforts to educate the public are effective for increasing use of disposal methods, the Government Accountability Office (GAO) says in a Tuesday (Sept. 3) report on opioid disposal.

September 04, 2019 | Daily News

HHS is granting more than $1.8 billion in funding to expand access to treatment and support near real-time data on drug overdoses, the agency announced Wednesday (Sept. 4).

August 29, 2019 | Daily News

Substance use disorder and mental health advocates are concerned that loosening the strict privacy scheme that protects substance use treatment records will make it easier for these records to get in the hands of law enforcement and could make people fearful of seeking treatment.

August 28, 2019 | Daily News

OxyContin maker Purdue Pharma and its owners, the Sackler family, offered to settle thousands of lawsuits against the company for $10 billion to $12 billion, according to media reports.

August 27, 2019 | Daily News

Democratic presidential candidate and South Bend, Indiana Mayor Pete Buttigieg unveiled a proposal Friday (Aug. 23) to tackle mental illness and substance use disorders by increasing Medicaid reimbursement for related services, requiring Medicare and Medicaid to cover medication-assisted treatment, and tackling social isolation and social determinants of health through Medicare and Medicaid interventions.

August 26, 2019 | Daily News

An Oklahoma judge determined that Johnson & Johnson and its subsidiary Janssen Pharmaceuticals played a role in the opioid crisis, and he ordered the company to pay more than $572 million based on public nuisance claims.

August 23, 2019 | Daily News

HHS’s long-awaited proposal to relax a strict privacy scheme protecting substance use records has renewed calls from both Senate and House lawmakers, including Energy & Commerce Republicans, to pass a bill going further than the proposed rule to fully align the scheme with the less-stringent Health Insurance Portability and Accountability Act (HIPAA).

August 22, 2019 | Daily News

Substance use record privacy restrictions would be loosened under a rule proposed Thursday (Aug. 22) by the Substance Abuse and Mental Health Services Administration (SAMHSA), but HHS Secretary Alex Azar said the administration is limited in fully aligning the scheme with the less-stringent Health Insurance Portability and Accountability Act (HIPAA) and would support congressional action to do so.

August 22, 2019 | Daily News

The number of Medicaid-covered prescriptions for buprenorphine, a key drug used to treat opioid addiction, increased dramatically in states that expanded Medicaid under the Affordable Care Act while remaining relatively static in non-expansion states, according to a new study from researchers at the Urban Institute.

August 21, 2019 | Daily News

CMS agreed to clarify diagnostic code requirements, assist states Medicaid agencies in correctly reporting the National Provider Identifiers (NPIs) of providers who prescribe opioids and ensure all beneficiaries can be uniquely identified in the national Medicaid claims database after an HHS Office of Inspector General (OIG) report said that national data are incomplete.

August 21, 2019 | Daily News

The White House Office of National Drug Control Policy issued advisories that explain how pharmaceutical and chemical supply companies can identify illicit fentanyl manufacturing and redistribution and prevent movement of fentanyl and other synthetic opioids into and within the United States.

August 20, 2019 | Daily News

Opioid maker Endo International’s subsidiaries, including Endo Pharmaceuticals and Par Pharmaceutical, have settled for $10 million with the plaintiffs in the ongoing multidistrict opioid litigation, the company announced Tuesday (Aug. 20).

August 20, 2019 | Daily News

FDA’s pediatric advisory committee will meet late next month to discuss the safety of opioids to manage pain in children, and to share the results of a study on the neuropsychiatric effects of an asthma drug called montelukast, more commonly known as Singulair.

Pages